Wang Christopher Min Fang 4

What happened

• Christopher Min Fang Wang, a director of STAAR SURGICAL CO (ticker: STAA), was granted a derivative award on March 6, 2026: options covering 7,524 shares. The reported acquisition price is $0.00, meaning no cash was paid at grant and the award has no immediate sale value. The options vest in full on the earlier of June 18, 2026 or the issuer’s 2026 annual meeting of shareholders.

Key details

• Transaction date: 2026-03-06 (Form 4 filed 2026-03-10).
• Transaction type/code: A — Grant/Award (derivative securities: stock options).
• Shares/options granted: 7,524 underlying shares.
• Price reported: $0.00 (no cash paid at grant).
• Vesting: 100% vesting on earlier of June 18, 2026 or the 2026 annual meeting (per footnote).
• Shares owned after transaction: Not stated in the Form 4 provided.
• Filing timeliness: Form 4 shows filing on Mar 10 for a Mar 6 transaction; the filing does not indicate a tardiness code in the summary provided here.

Context

• This was a grant of stock options (a compensation award), not a market purchase or sale. Such awards represent potential future equity if vested and exercised; they do not reflect an immediate change in market exposure. No sale, exercise, or cashless transaction is reported here.